1986
DOI: 10.1159/000472608
|View full text |Cite
|
Sign up to set email alerts
|

Intracavernous Injection of Noradrenaline to Interrupt Erections during Surgical Interventions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
8
0

Year Published

1989
1989
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(8 citation statements)
references
References 3 publications
0
8
0
Order By: Relevance
“…Moloney et al (1975) found that epidural anesthesia combined with chlorpromazine‐induced hypotension results in transient penile flaccidity only at a systolic blood pressure equal to or less than 70 mm Hg; this technique is not indicated for the increased venous drainage. de Meyer and de Sy (1986) recommended intracavernous injection of noradrenaline to interrupt erections during transurethral procedures. Shantha (1989) has recommended the use of terbutaline (5 mg orally or 0.25–0.5 mg subcutaneously or intravenously) for the treatment of intraoperative penile erection.…”
Section: Discussionmentioning
confidence: 99%
“…Moloney et al (1975) found that epidural anesthesia combined with chlorpromazine‐induced hypotension results in transient penile flaccidity only at a systolic blood pressure equal to or less than 70 mm Hg; this technique is not indicated for the increased venous drainage. de Meyer and de Sy (1986) recommended intracavernous injection of noradrenaline to interrupt erections during transurethral procedures. Shantha (1989) has recommended the use of terbutaline (5 mg orally or 0.25–0.5 mg subcutaneously or intravenously) for the treatment of intraoperative penile erection.…”
Section: Discussionmentioning
confidence: 99%
“…To date, many pharmacological treatments to produce detumescence have been proposed, such as intracavernous injection of ephedrine, phenylephrine, metaraminol, noradrenaline and adrenaline [4,[7][8][9][10] or intravenous injection of ketamine [6,[11][12][13], dexmedetomidine [5], terbutaline [14] and glycopyrrolate [15].…”
Section: Introductionmentioning
confidence: 99%
“…This challenge should be weighted between operating on ill-patient facing the challenges of general anaesthesia and a conscious patient with the option of better recovery profile and earlier discharge from the hospital. Although many pharmacologic agents [12,13,14] have been used to treat tumescence that arises from the effect of anaesthesia, the attending surgeon should properly evaluate the patient for co-morbidities and agent (s) used as some of these medications could have deleterious effect.…”
Section: Discussionmentioning
confidence: 99%